Argenica Therapeutics Limited (ASX:AGN)
Australia
· Delayed Price · Currency is AUD
0.6750
+0.0350 (5.47%)
Apr 24, 2025, 12:55 PM AEST
Argenica Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Net Income | -5.26 | -5.48 | -4.82 | -4.09 | -1.03 | -0.66 |
| Stock-Based Compensation | 0.14 | 0.14 | 0.46 | 0.43 | 0.27 | - |
| Change in Accounts Receivable | -0.23 | -0.23 | -0.07 | -0 | -0.09 | -0.06 |
| Change in Accounts Payable | 0.45 | 0.45 | 0.46 | 0.29 | -0.2 | 0.62 |
| Change in Unearned Revenue | 0.05 | 0.05 | 0.66 | - | - | - |
| Change in Other Net Operating Assets | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | - |
| Operating Cash Flow | -5.1 | -5.06 | -3.3 | -3.36 | -1.05 | -0.1 |
| Investment in Securities | - | 0.05 | -0.05 | - | - | - |
| Investing Cash Flow | - | 0.05 | -0.05 | - | - | - |
| Issuance of Common Stock | 11.76 | 11.63 | 3.73 | 5.13 | 7.85 | 0.69 |
| Other Financing Activities | -0.01 | - | 0 | 0 | 0 | - |
| Financing Cash Flow | 11.75 | 11.63 | 3.73 | 5.13 | 7.85 | 0.69 |
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 |
| Net Cash Flow | 6.65 | 6.62 | 0.37 | 1.77 | 6.8 | 0.59 |
| Cash Interest Paid | 0 | 0 | 0 | 0 | 0 | - |
| Cash Income Tax Paid | - | -2.09 | -1.38 | -0.26 | -0.15 | - |
| Levered Free Cash Flow | -3.37 | -3.11 | -1.52 | -1.82 | -0.4 | - |
| Unlevered Free Cash Flow | -3.37 | -3.11 | -1.52 | -1.82 | -0.4 | - |
| Change in Net Working Capital | -0.05 | -0.29 | -1.07 | -0.31 | 0.03 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.